Alström Syndrome is a rare, multi-system genetic condition in which progressive vision loss is typically one of the earliest and most consistently recognised features, often noticed well before some of the syndrome’s other findings become apparent. Unlike Bardet-Biedl Syndrome, which follows a rod-cone pattern, Alström Syndrome typically causes a cone-rod dystrophy, meaning central and colour vision are affected relatively early in the disease course.
Ghanaian families are guided through an evaluation that recognises this as a whole-body condition — working alongside existing local care for the syndrome’s other systemic aspects — while concentrating the retinal work-up on the specific pattern of cone-rod involvement that sets Alström Syndrome apart from other inherited dystrophies.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Given how early visual symptoms typically appear, the retinal care plan for Alström Syndrome places particular emphasis on timely evaluation for stem cell therapy in eligible patients and on early low-vision strategies suited to a young child, alongside coordination with the family’s existing care for the syndrome’s other systemic features.
“This is a recognised pattern specific to Alström Syndrome — it typically follows a cone-rod course, meaning central and colour vision are affected relatively early, unlike the more common rod-first pattern seen in classic retinitis pigmentosa.”
”
They are different conditions with some overlapping systemic features, but they arise from different genes and follow different retinal patterns — Alström typically affects central vision earlier (cone-rod), while Bardet-Biedl more often follows the rod-first pattern typical of classic RP. Genetic testing distinguishes between the two.”
“Alström Syndrome can involve other systems including hearing, heart, and metabolic function, so ongoing coordination with the relevant specialists managing those aspects locally in Ghana remains important alongside the retinal evaluation we provide.”
“Given how early visual symptoms tend to appear in this condition, there’s generally no benefit to waiting — an early baseline assessment helps establish the starting point against which any future changes can be measured.”
